ExThera Medical Exhibits at the 2023 International Conference on Extracorporeal Organ Support in Zagreb, Croatia
Retrieved on:
Tuesday, June 6, 2023
Biotechnology, FDA, Health, Other Health, Pharmaceutical, Surgery, Other Science, Research, Medical Devices, Infectious Diseases, General Health, Science, COVID-19, Clinical Trials, Seraph, Trial of the century, Presidents' Conference Committee (Toronto streetcar), Septic, VEGI, Hospital, 2023 International Conference on Climate Resilient Pakistan, MD, Patient, Conference, Bloodstream infections, ASTREA, Pharmaceutical industry
ExThera Medical, a healthcare company that has developed and commercialized a unique extracorporeal blood filtration medical device, participated in the annual International Conference on Extracorporeal Organ Support.
Key Points:
- ExThera Medical, a healthcare company that has developed and commercialized a unique extracorporeal blood filtration medical device, participated in the annual International Conference on Extracorporeal Organ Support.
- Throughout the conference, the Seraph® 100 MicroBind® Affinity Blood Filter was featured as a therapy with established clinical utility for broad bacterial, viral, and fungal pathogen removal, with academic faculty presentations highlighting published data and successful patient treatments therein.
- There is a lot of potential for the Seraph 100 to prove itself in rigorous clinical trials,” said Thomas Rimmele, MD, and conference faculty.
- Additional presentations featured during the May 4-6 conference focused on the clinical efficacy and implementation of Seraph 100 for the purpose of treating critically ill patients suffering from bloodstream infections.